Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.33
13
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Oncoclinicas do Brasil Servicos Medicos SA
Oncoclinicas do Brasil Servicos Medicos SA
PP&E Net
Oncoclinicas do Brasil Servicos Medicos SA
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
|
PP&E Net
R$1.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Fleury SA
BOVESPA:FLRY3
|
PP&E Net
R$2.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
19%
|
|
|
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
|
PP&E Net
R$788.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
D
|
Diagnosticos da America SA
BOVESPA:DASA3
|
PP&E Net
R$6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
39%
|
CAGR 10-Years
24%
|
|
Oncoclinicas do Brasil Servicos Medicos SA
Glance View
Oncoclínicas do Brasil Serviços Médicos SA operates as a holding company, which engages in oncology clinics through the health care segment. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2021-08-10. The firm provides of medical services focused on Oncology. The Company, since its foundation, in addition to acting directly in the treatment of cancer patients, has dedicated itself to the study and identification of the appropriate therapy opportunities for patients and the growth trends in the sector. The firm holds interest in a number of subsidiaries, such as Centro de Quimioterapia Antiblastica e Imunoterapia SA, Centro Mineiro de Infusoes SA, and Centro Paulista de Oncologia SA.
See Also
What is Oncoclinicas do Brasil Servicos Medicos SA's PP&E Net?
PP&E Net
1.2B
BRL
Based on the financial report for Dec 31, 2023, Oncoclinicas do Brasil Servicos Medicos SA's PP&E Net amounts to 1.2B BRL.
What is Oncoclinicas do Brasil Servicos Medicos SA's PP&E Net growth rate?
PP&E Net CAGR 5Y
37%
Over the last year, the PP&E Net growth was 13%. The average annual PP&E Net growth rates for Oncoclinicas do Brasil Servicos Medicos SA have been 26% over the past three years , 37% over the past five years .
You don't have any saved screeners yet
